- Filed
- Oct 17, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Oct 15, 2024 | 530.7M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 522.69M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2023 | 418.82M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $572.76K |
| Capex | Q1 2025 · Mar 31, 2023 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$47.44K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2023 | −$28.62K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $35.46K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $240.65K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$775.61K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$1.28M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2023 | −$56.51K |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2022 | −$25.42K |
| Total Liabilities | Q1 2025 · Mar 31, 2024 | $852.24K |
| Total Liabilities | Q1 2025 · Dec 31, 2023 | $1.53M |
| Current Assets | Q1 2025 · Mar 31, 2024 | $71.24K |
| Current Assets | Q1 2025 · Dec 31, 2023 | $240.65K |
| Total Assets | Q1 2025 · Mar 31, 2024 | $76.63K |
| Total Assets | Q1 2025 · Dec 31, 2023 | $247.22K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Diluted | Q1 2025 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2023 | $0.00 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.82M |
| Net Income restated | Q1 2025 · Mar 31, 2023 | −$31.09K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$4.54M |
| Operating Income restated | Q1 2025 · Mar 31, 2023 | −$29.8K |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Revenue restated | Q1 2025 · Mar 31, 2023 | $0 |